Veracyte, Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Brent Shafer

Veracyte, Inc.’s own tally for this item (“Elect Director: Brent Shafer”): 73,028,595 for, 102,213 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were nominated to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified: Each of the nine nominees for director was elected to serve until the 2027 annual meeting of stockholders and until their successors are duly elect…”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 45,434,437 for, 16,994 abstained, 57,127 not voted.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Eliav Barr

Veracyte, Inc.’s own tally for this item (“Elect Director: Eliav Barr”): 73,049,803 for, 80,948 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were nominated to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified: Each of the nine nominees for director was elected to serve until the 2027 annual meeting of stockholders and until their successors are duly elect…”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 45,434,437 for, 16,994 abstained, 57,127 not voted.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Evan Jones

Veracyte, Inc.’s own tally for this item (“Elect Director: Evan Jones”): 70,657,221 for, 2,462,244 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were nominated to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified: Each of the nine nominees for director was elected to serve until the 2027 annual meeting of stockholders and until their successors are duly elect…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 45,410,102 for, 24,335 against, 16,994 abstained, 57,127 not voted.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Jens Holstein

Veracyte, Inc.’s own tally for this item (“Elect Director: Jens Holstein”): 72,977,470 for, 152,302 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were nominated to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified: Each of the nine nominees for director was elected to serve until the 2027 annual meeting of stockholders and until their successors are duly elect…”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 45,434,436 for, 16,994 abstained, 57,127 not voted.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Karin Eastham

Veracyte, Inc.’s own tally for this item (“Elect Director: Karin Eastham”): 70,956,821 for, 2,173,874 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were nominated to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified: Each of the nine nominees for director was elected to serve until the 2027 annual meeting of stockholders and until their successors are duly elect…”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 45,416,652 for, 17,785 against, 16,994 abstained, 57,127 not voted.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Marc Stapley

Veracyte, Inc.’s own tally for this item (“Elect Director: Marc Stapley”): 72,204,529 for, 924,760 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were nominated to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified: Each of the nine nominees for director was elected to serve until the 2027 annual meeting of stockholders and until their successors are duly elect…”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 45,354,410 for, 80,027 against, 16,994 abstained, 57,127 not voted.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Muna Bhanji

Veracyte, Inc.’s own tally for this item (“Elect Director: Muna Bhanji”): 71,859,549 for, 1,158,339 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were nominated to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified: Each of the nine nominees for director was elected to serve until the 2027 annual meeting of stockholders and until their successors are duly elect…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 45,347,922 for, 86,515 against, 16,995 abstained, 57,127 not voted.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Robert S. Epstein

Veracyte, Inc.’s own tally for this item (“Elect Director: Robert S. Epstein”): 67,973,349 for, 5,078,388 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were nominated to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified: Each of the nine nominees for director was elected to serve until the 2027 annual meeting of stockholders and until their successors are duly elect…”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 43,895,093 for, 1,539,342 against, 16,994 abstained, 57,127 not voted.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: The election of nine directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified: Tom Miller

Veracyte, Inc.’s own tally for this item (“Elect Director: Tom Miller”): 72,957,793 for, 172,925 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The following directors were nominated to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified: Each of the nine nominees for director was elected to serve until the 2027 annual meeting of stockholders and until their successors are duly elect…”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 111 asset managers below reported 45,434,436 for, 1 against, 16,994 abstained, 57,127 not voted.

Showing the 25 largest of 111 asset managers. See all 111 in the interactive database.

Description as filed by funds: The approval of an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan.

Veracyte, Inc.’s own tally for this item (“4. The approval of the 2023 Plan Amendment”): 52,059,077 for, 21,060,296 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 71% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Veracyte, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Amend Omnibus Stock Plan” (2 managers, 11,390 against, 57,127 not voted).

The 112 asset managers below reported 37,256,547 for, 8,187,299 against, 19,161 abstained.

Showing the 25 largest of 112 asset managers. See all 112 in the interactive database.

Description as filed by funds: The approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in our proxy statement.

Veracyte, Inc.’s own tally for this item (“3. The approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers”): 71,266,771 for, 1,858,805 against, per its Form 8-K filed June 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 110 managers: 45,472,528 for, 28,854 against, 16,994 abstained, 57,127 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 302 managers: 43,265,715 for, 1,583,878 against, 4,315 not voted, 864,568 mixed. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: The ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026.

Veracyte, Inc.’s own tally for this item (“2. The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026”): 75,452,164 for, 379,788 against — passed, per its Form 8-K filed June 11, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 112 asset managers below reported 45,442,020 for, 167 against, 16,994 abstained, 57,127 not voted.

Showing the 25 largest of 112 asset managers. See all 112 in the interactive database.